Steven Mansoor is a Cardiology physician.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3181 SW Sam Jackson Park Rd
Portland, OR 972393011
Telephone
503-494-8211Registry record last updated 25 Jul 2017.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
82.3%Beta blocker22.6%Carvedilol47%Metoprolol Succinate38%Metoprolol Tartrate10%Propranolol Hcl5%Part D<11 patientsStatin19.5%Atorvastatin Calcium61%Rosuvastatin Calcium39%Part D≥36 patients+ 10 more classes in this area
Blood & clotting
11.1%Factor Xa inhibitor9.2%Eliquis100%Part D≥28 patientsP2Y12 inhibitor1.9%Clopidogrel100%Part D<11 patientsMetabolism & gastrointestinal
6.6%SGLT2 inhibitor3%Jardiance61%Farxiga39%Part D<11 patientsPotassium supplement2.3%Potassium Chloride100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
5 NIH research awards on record, funded 2002–2025 per NIH RePORTER. The latest:
- Elucidation of P2X7 Receptor Signaling and Development of Novel Small Molecule and Aptamer Ligand Therapies
Oregon Health & Science University
FY2025$936,000DP2GM149551 - Elucidation of P2X7 Receptor Signaling and Development of Novel Small Molecule and Aptamer Ligand Therapies
Oregon Health & Science University
FY2022$1,340,100DP2GM149551 - Structure/Function Studies on the Mechanisms of Purinergic Receptor Activation and Antagonism
Oregon Health & Science University
FY2022$248,760R00HL138129
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”